GARDASIL - Medsafe
WPC-V501-I-022011 1 NEW ZEALAND DATA SHEET . GARDASIL® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant vaccine] DESCRIPTION
Download GARDASIL - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
GARDASIL9 - Merck.com | Homepage
www.merck.com1 Patient Information about GARDASIL®9 (pronounced “gard-Ah-sill nīn”) (Human Papillomavirus 9-valent Vaccine,Recombinant) Read this information with care before getting GARDASIL®9.
HIGHLIGHTS OF PRESCRIBING INFORMATION Each …
www.merck.com3 2 DOSAGE AND ADMINISTRATION 2.1 Dosage Each dose of GARDASIL 9 is 0.5-mL. Administer GARDASIL 9 as follows: Age Regimen Schedule 9 …
HPV (Human Papillomavirus) Vaccine: What You …
immunize.orgProblems that could happen after any injected vaccine: •People sometimes faint after a medical procedure, including vaccination. Sitting or lying down for about
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4 As with any vaccine, vaccination with Gardasilmay not result in protection in all vaccine recipients. Gardasil will only protect against diseases that are caused by HPV types6, 11, 16 and 18 and to a
HPV Vaccine – 2 or 3 Doses?
eziz.orgIMM-1254 (10/17) 9˜14 YEARS 1 2 DOSES 3 DOSES For Health Professionals 15+ YEARS 4 OR COMPROMISED IMMUNE SYSTEM3 For more information, see: www.cdc.gov/vaccines/hcp/acip-recs/vacc-speci˚c/hpv.html
Prospecto: Información para el usuario Gardasil ...
www.msd.esSe recomienda que si usted o su hijo recibieron una primera dosis de Gardasil 9 completen el régimen de vacunación con Gardasil 9.
MERCK VACCINE PATIENT ASSISTANCE PROGRAM …
www.merckhelps.comSECTION 1: Applicant Information (Patient should complete all information in Section 1.) Patient’s First Name US Resident* Yes No Last Name Address Apt. No.
FOLLETO DE INFORMACIÓN AL PROFESIONAL …
www.ispch.cls-ccds-v503-i-022015 folleto de informaciÓn al profesional gardasil 9 vacuna nonavalente antivirus papiloma humano recombinante adsorbida, suspensiÓn inyectable
Gardasil 9 supply, influenza, zoster vaccine, NIR and …
www.influenza.org.nzNIR and PMS changes The NIR, practice management systems (PMS) and Ministry payment systems are being updated to include the funded zoster vaccine.